Skip to main content

Search

Search the site:

News, Views, and Advocacy From the Oncology Nursing Society

News & Views

Advocacy

Stories

News & Views

Latest Articles
Clinical Practice
ONS News
ONS Leadership

Trending Topics

Treatments
Research
Safety
COVID-19
Drug Reference Sheet
Clinical practice

View All Topics

Advocacy

Latest Articles
Updates
Get Involved

Stories View All

View All

As Oncology Nurses, We Are the Fish

Oncology nurse pride

As Oncology Nurses, We Are the Fish

Patients and the Public Recognize and Thank Dedicated Nurses

Nurse empowerment

Patients and the Public Recognize and Thank Dedicated Nurses

How to Promote and Maintain Cancer Screening as COVID-19 Persists

Cancer screening

How to Promote and Maintain Cancer Screening as COVID-19 Persists

I’m a Match: My Journey From Advanced Practice BMT Nurse to Stem Cell Transplant Donor

Oncology nurse pride

I’m a Match: My Journey From Advanced Practice BMT Nurse to Stem Cell Transplant Donor

February 11, 2022

Online and Mobile Resources Prepare Oncology Professionals for Care Delivery in All Settings

Oncology nurse pride

Online and Mobile Resources Prepare Oncology Professionals for Care Delivery in All Settings

January 31, 2022

Search

News & Views

Advocacy

Stories

Home

Author Content

Cancer research

E-Cigarettes Increase Risk of Lung and Bladder Cancer More Than Traditional Cigarettes

People with a history of e-cigarette use have a higher risk of developing both lung and bladder cancer than never smokers or even users of regular cigarettes, according to study findings researchers reported during the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium.

Cancer research

AI Ultrasound Is Nearly 100% Accurate in Detecting Thyroid Cancers

Ultrasound imaging guided with artificial intelligence (AI) noninvasively detects almost all malignant thyroid nodules, researchers reported at the 2022 Multidisciplinary Head and Neck Cancers Symposium. It is also accurate when predicting T stage, extracapsular extension, and presence of a BRAF variant.

Cancer health disparities

Oncology Navigation Standards Help Patients Overcome Disparities and Barriers to Care

Patients with cancer, especially those from underrepresented groups or who are experiencing racism, inequalities, social determinants of health factors, and other barriers to care, need oncology nurse navigation now more than ever before. Developed as a “strategy to improve outcomes in marginalized populations by eliminating barriers to timely diagnosis and treatment of cancer and other chronic diseases,” navigation has made a difference for patients since its introduction in 1990.

More Patients Are Skipping Their Cervical Cancer Screenings

Nearly a quarter of patients who are eligible for cervical cancer screening are overdue for their current tests, researchers said in study findings published in JAMA Network Open. The number grew nearly 10% since 2005—representing a steady increase in missed screening over time—and was higher in different sociodemographic groups because of factors related to social determinants of health.

Cancer research

Targeting Beta2-Spectrin Could Prevent Biggest Contributor to Increasing HCC Rates

Excessive amounts of a protein called beta2-spectrin may put people at increased risk for nonalcoholic steatohepatitis (NASH), which is the leading cause of hepatocellular carcinoma (HCC), researchers said in a report published in Science Translational Medicine. Developing treatments to lower the protein may help reduce the incidence of both diseases.

Cancer research

First-Line Combination Immunotherapy Prolongs Survival in BRAF Advanced Melanoma

Initial treatment with two monoclonal antibodies significantly improves survival for patients with BRAF V600-variant advanced melanoma compared to treatment with two targeted agents, researchers reported during the November 2021 ASCO Plenary Series meeting. The initial findings were so conclusive that the study’s data safety and monitoring board stopped the trial early.

Breast-Conserving Surgery Leads to Better QOL for Young Breast Cancer Survivors

Patients younger than 40 who elected to have breast-conserving surgery instead of mastectomy to remove breast cancer reported having better quality of life (QOL) more than five years after diagnosis, according to study findings reported in JAMA Surgery.

Oncology nursing roles

Climate Change Is Contributing to the Cancer Burden, and Nurses Must Take Action

Climate change affects more than weather patterns or the environment; it also has a substantial impact on human health. Its contribution to the cancer burden includes increased levels of carcinogens, comorbidity factors, cancer incidence, and cancer mortality and reduced access to care.

Cancer research

E-Cigarettes Are Not an Effective Smoking Cessation Strategy

Smokers who try to quit by switching to e-cigarettes do not have more success than those who use other smoking cessation strategies and in fact may be more likely to relapse, researchers found. They reported their study results in Tobacco Control.

Fiber—but Not Probiotics—Boosts Immunotherapy Response for Melanoma

Patients with melanoma who consume a high-fiber diet during treatment with immune checkpoint inhibitors (ICIs) or anti-PD-1 therapy experience longer progression-free survival than those who don’t, researchers reported in Science. And probiotic supplementation, often considered a healthy behavior, reduces immunotherapy response.

Patient financial advocacy

Even Insured Patients With Advanced Cancer Experience Financial Toxicity

As many as 71% of patients with advanced cancer—most of whom have healthcare insurance—experience major financial hardship because of their disease, according to study findings published in the Journal of the National Cancer Institute.

Cancer research

Rural Populations’ Fatalistic Perceptions About Cancer May Contribute to Cancer Disparities

Compared to people living in urban areas, on a nationwide U.S. survey, rural populations were more likely to report believing that cancer is unpreventable and always fatal. Researchers reported the survey findings and analysis in Cancer Epidemiology, Biomarkers, and Prevention.

Cancer research

Nursing Considerations for ICI-Related Myocarditis

Before immunotherapies like immune checkpoint inhibitors (ICIs) became a cancer treatment option, myocarditis typically developed in the presence of infections, drug allergies, or autoimmune diseases. Activating the immune system with ICIs can also trigger autoimmune-like adverse events such as myocarditis, and although its incidence in patients with cancer is low, mortality is high.

Cancer health disparities

Specialized Risk Calculator May Reduce Disparities for Black Patients With Breast Cancer

A new risk model tailored for Black patients predicts their risk of developing breast cancer as accurately as current models for White patients, researchers reported in the Journal of Clinical Oncology. Because Black patients are more likely to be younger at diagnosis, present with aggressive or advanced cancer, and die from the disease than other racial and ethnic groups, using the new model to personalize prevention and screening recommendations may reduce those disparities.

Test article scheduling

February 25, 2022

test scheduler

February 24, 2022

Cancer research

Immune Checkpoint Inhibitors May Increase Risk of Serious Infection

Nearly a quarter of patients receiving a variety of drugs classified as immune checkpoint inhibitors develop infections during treatment and 15% are considered severe, researcher reported in study findings published in Cancer Medicine.

February 23, 2022

Cancer research

Immunotherapy After Surgery May Prevent Early-Stage Melanoma Recurrence

Completing up to a year of pembrolizumab immunotherapy after surgical resection of stage IIB or IIC melanoma decreases patients’ risk for disease recurrence or death by 35%, according to study findings presented at the European Society for Medical Oncology 2021 annual meeting. The new findings led the U.S. Food and Drug Administration to expand its approval of pembrolizumab to use as adjuvant therapy in both adults and children aged 12 and older with early-stage melanoma.

February 16, 2022

Test article scheduling

February 10, 2022

Cancer research

Geriatric Assessments Reduce Side Effect Incidence in Older Adults With Cancer

Regularly conducting geriatric assessments in older patients and using the information to guide their care reduces their risk of side effects by nearly 30%, researchers reported in study findings published in Lancet.

February 09, 2022

Combination therapy

Nursing Considerations for Isatuximab Combination Therapy

Clinicians often use combination cancer therapies to overcome treatment resistance, and one of the newest options for certain patients with multiple myeloma is isatuximab, a monoclonal antibody (mAb). Approved for use in combination with pomalidomide plus dexamethasone to treat adults with relapsed or refractory multiple myeloma who have received at least two prior therapies, isatuximab prolonged progression-free survival by nearly six months and produced an overall response rate of more than 60% in the drug’s clinical trials.

February 08, 2022

Cancer research

Combination CDK4/6 and Fulvestrant Has Survival Benefits in Late-Stage Breast Cancer

Combining a CDK4/6 inhibitor and fulvestrant improves overall survival consistently among patients with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer, according to a U.S. Food and Drug Administration (FDA) analysis. The agency reported the findings in Lancet Oncology.

February 02, 2022

Never Smokers With Lung Cancer May Have One of Three Molecular Subtypes

Most lung cancers in patients who have no smoking history are the result of natural genetic variants in the body that can be classified into one of three molecular subtypes, researchers reported in study finding published in Nature Genetics.

January 26, 2022

Cancer research

Cancer Cells’ Aneuploidy May Be Why They Resist Treatment

The extra or missing chromosomes—also called aneuploidy—in 90% of cancer cells may be a factor in treatment resistance, a new study shows. Researchers reported the findings in Developmental Cell.

January 19, 2022

Cancer research

Fructose Fuels Colorectal Cancer Growth, Study Shows

Excess consumption of fructose in additives like table sugar or high-fructose corn syrup (HFCS) not only contributes to obesity, but it may increase colorectal cancer (CRC) cell survival, leading to larger tumors and increased symptom burden in patients at higher risk, researchers showed in study results published in Nature. However, blocking the body’s uptake of the sweetener may be a key to controlling the disease.

January 12, 2022

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

To discuss the information in this article with other oncology nurses, visit the ONS Communities.

To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

content['#byline_profile'].image_alt_text

Elisa Becze BA, ELS, Editor

News, Views, and Advocacy From the Oncology Nursing Society

Legal Notices

Contact Us

Conferences

Advertising

Newsroom

Sitemap

Oncology Nursing Foundation

© Copyright 2022 Oncology Nursing Society

Back to Top ▲